Oxford trial funded by UKRI offers new hope for a COVID vaccine

Early stage human trials of a COVID-19 vaccine have found it produces strong immune response and shows no early safety concerns, according to results published today inThe Lancet. 
Source: Medical Research Council General News - Category: Research Source Type: news
More News: COVID-19 | Research | Vaccines